Flow Immunology
Jump To:
A | |
02/20/2024 | Activated T-Cell Panel |
02/20/2024 | ALPS Panel |
02/20/2024 | Antibodies to Extactable Nuclear Antigens |
B | |
02/20/2024 | B-Cell Phenotype Profile |
C | |
02/20/2024 | CD 19/20 Rituximab Panel |
02/20/2024 | CD34 Absolute Count |
02/20/2024 | CD4 T-Cell Recent Thymic Emigrants (RTE) |
02/20/2024 | CD4/CD8 Panel, Blood |
02/20/2024 | Cytokine Inflammation 4 Plex Panel |
02/20/2024 | Cytokine Panel 13, Serum |
02/20/2024 | Cytokine Storm 4 Plex Panel |
L | |
02/20/2024 | Leukemia/Lymphoma Panel |
02/20/2024 | Lymphocyte Enumeration- ALPS Panel |
M | |
02/20/2024 | Minimal Residual Disease (MRD) Flow Cytometry for B-ALL (UM) |
02/20/2024 | Minimal Residual Disease (MRD) University of Washington |
Q | |
02/20/2024 | Quantitative Lymphocyte Subsets: T,B,NK |
R | |
02/20/2024 | Reflexive Antinuclear Antibody Profile |
S | |
02/20/2024 | Soluble CD163 (SCD163) |
T | |
02/20/2024 | T-Cell Receptor Excision Circles (TREC) Analysis |